When dosed in combination with an adenovirus-based or irradiated sporozoite-based prophylactic malaria vaccine, LD01 enhances antigen-specific CD8+ T cell expansion supporting PD1 regulation of naïve-to-antigen-specific effector T cell transition and differentiation (34, 36, 37). Here, CD8A is linked to malaria.